Video

Jeffrey Cohen, MD, Discusses New MS Criteria

Author(s):

The director of experimental therapeutics at the Mellen MS Center at the Cleveland Clinic shared what's shaping the soon-to-be-released update on the most recent 2010 diagnosing criteria at the 2017 Consortium of Multiple Sclerosis Centers.

The committee for the International Diagnostic Criteria for Multiple Sclerosis will be releasing its first update of multiple sclerosis (MS) diagnosing standards since 2010, later this year.

Jeffrey Cohen, MD, director of experimental therapeutics at the Mellen MS Center at the Cleveland Clinic, shared his inside-track knowledge of the machinations and discussions being had by the criteria-setters at the 2017 Consortium of Multiple Sclerosis Centers (CMSC) in New Orleans this week.

Cohen sat down during CMSC to talk new criteria details, where issues lie in MS misdiagnosis, and how new forms of treatment could potentially influence diagnoses.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.